Returns–Not enough quarters yet
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| CVXChevron Corp New | $16.1M | 9.2% | +30.2% |
| MISTMilestone Pharmaceuticals In | $12.2M | 6.9% | |
| INTUIntuit | $10.1M | 5.7% | New |
| QCOMQualcomm Inc | $9.1M | 5.2% | New |
| BBarrick Mng Corp | $8.1M | 4.6% | |
| TXTTextron Inc | $7.7M | 4.4% | +97.4% |
| REGNRegeneron Pharmaceuticals | $6.2M | 3.5% | +25.3% |
| NVDANvidia Corporation | $5.2M | 3.0% | +62.5% |
| ARQTArcutis Biotherapeutics Inc | $4.9M | 2.8% | |
| SPRYSilverback Therapeutics Inc | $4.6M | 2.6% | |
| MUMicron Technology Inc | $4.6M | 2.6% | New |
| BTGB2gold Corp | $4.4M | 2.5% | |
| LGNDLigand Pharmaceuticals Inc | $3.5M | 2.0% | |
| CGAUCenterra Gold Inc | $3.1M | 1.8% | |
| NEMNewmont Goldcorp Corporation | $3.0M | 1.7% | |
| SLBSchlumberger Ltd | $2.8M | 1.6% | +281.2% |
| HRMYHarmony Biosciences Hldgs In | $2.7M | 1.5% | |
| Royalty Pharma PLC ShsCUSIP G7709Q104 | $2.5M | 1.4% | |
| AMDAdvanced Micro Devices Inc | $2.3M | 1.3% | |
| Newamsterdam Pharma Company OrdinaryCUSIP N62509109 | $2.3M | 1.3% | +82.0% |
| SSRMSsr Mng Inc | $2.1M | 1.2% | |
| SKYDParamount Skydance Corp Com | $2.1M | 1.2% | |
| DOUGDouglas Elliman Inc | $1.8M | 1.0% | |
| EWSIshares Inc Msci Singpor | $1.8M | 1.0% | |
| BIOBio Rad Labs Inc | $1.8M | 1.0% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| AMDAdvanced Micro Devices Inc | December 31, 2025 | +171.3% | $2.3M |
| NOKNokia Corp | December 31, 2025 | +105.3% | $930K |
| OSUROrasure Technologies Inc | December 31, 2025 | +84.3% | $977K |
| LGNDLigand Pharmaceuticals Inc | December 31, 2025 | +67.2% | $3.5M |
| Royalty Pharma PLC ShsCUSIP G7709Q104 | December 31, 2025 | +45.1% | $2.5M |
| SSRMSsr Mng Inc | December 31, 2025 | +29.0% | $2.1M |
| Ubs Group AgCUSIP H42097107 | March 31, 2026 | +26.8% | $942K |
| HALHalliburton Co | December 31, 2025 | +20.1% | $1.6M |
| ERICEricsson | December 31, 2025 | +15.5% | $1.1M |
| CGAUCenterra Gold Inc | December 31, 2025 | +10.4% | $3.1M |
Sold off last quarter
- OGNOrganon & Co Common was $2.0M
- SPHRSphere Entertainment Co was $1.4M
- Esperion Therapeutics Inc NeCUSIP 29664W105 was $1.1M
- HPEHewlett Packard Enterprise C was $976K
- Fonar CorpCUSIP 344437405 was $275K
- Uniqure NvCUSIP N90064101 was $160K
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +3.9% | +14.8% |
| March 31, 2026 | −9.4% | −4.6% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Pavaki Capital Management LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2143027&type=13F-HR&dateb=&owner=include&count=40CIK 2143027
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/2143027/000214302726000008/Filed August 7, 2026 · accession 0002143027-26-000008